Texas SB 426: Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Status: Referred to Public Health (as of 2023-04-17)

State: Texas · Session: 88 · Bill: SB 426

Subjects: COVID-19 (SB9YM), Health Care Providers (I0387), Health--General (I0385), Health--Other Diseases & Medical Conditions (I0383), MEDICAL BOARD, TEXAS (V0644), MEDICINE & PRESCRIPTION DRUGS (S7338), RIGHT TO TREAT ACT (P17XY)

Sponsors: Paxton, Hall

View Texas SB 426 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.